Real-World Treatment Efficacy and Safety Profile of Sofosbuvir- and Velpatasvir-Based HCV Treatment in South Korea: Multicenter Prospective Study
In this first prospective real-world study in South Korea, SOF/VEL-based regimens demonstrated excellent efficacy and safety, achieving 100% SVR12 in the per-protocol population, including patients with cirrhosis and prior treatment failure.
Authors
- Sung Kyu Choi
- Sung Bum Cho
- Ju‐Yeon Cho (ORCID: https://orcid.org/0000-0002-2686-7812)
- Jae Hyun Yoon (ORCID: https://orcid.org/0000-0002-4993-2496)
- Jin-Dong Kim (ORCID: https://orcid.org/0000-0001-9660-6303)
- Jin Won Kim (ORCID: https://orcid.org/0000-0002-1357-7015)
- Chang‐Hun Lee (ORCID: https://orcid.org/0000-0003-4330-7726)
- Ga Ram You (ORCID: https://orcid.org/0000-0002-7001-7372)
- Hoon Gil Jo (ORCID: https://orcid.org/0000-0002-0947-7185)
Institutions
- Chonnam National University Hospital (KR)
- Chosun University Hospital (KR)
- Cheju Halla General Hospital (KR)
- Chonnam National University Hwasun Hospital (KR)
- Wonkwang University (KR)
- Jeonbuk National University (KR)
Publication Details
- Journal
- Viruses
- Published
- 2025-07-04
- DOI
- https://doi.org/10.3390/v17070949
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.32